Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole in Co-diagnosed NERD and Chronic Gastritis
NCT01119768Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole in non-erosive reflux disease (NERD) and chronic gastritis (2 arms), sponsored by AstraZeneca. Primary endpoint: Symptom Control Rate at 24 Weeks Assessed by Gerd Q Questionnaire. Started Apr 2010; status: completed.
02
Drugs
esomeprazole
03
Conditions
non-erosive reflux disease (NERD)chronic gastritis
Beyond the preview
Go deeper on NCT01119768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119768.